Drug
Aa4500
Aa4500: highest development phase Phase 3, developed by Endo. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Endo
Trials
| Drug | Phase | Indication |
|---|---|---|
| AA4500 NCT02267460 | Phase 3 | Peyronie's Disease |
| AA4500 NCT01430169 | Phase 2 | Peyronie's Disease |
Latest
No recent events.
Follow Aa4500 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.